Protocadherin 10 is frequently downregulated by promoter methylation and functions as a tumor suppressor gene in non-small cell lung cancer

Cancer Biomarkers

Volumn 12, Issue 1, 2012, Pages 11-19

  Tang, Xiaokui ^a   Yin, Xuedong ^a   Xiang, Tingxiu ^a   Li, Hongzhong ^a   Li, Fan ^a   Chen, Li ^a   Ren, Guosheng ^a  

^a THE FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Methylation; Non small cell lung cancer; Promoter; Protocadherin 10

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; CADHERIN; MESSENGER RNA; PROTOCADHERIN 10; TRICHOSTATIN A; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CANCER CELL CULTURE; CELL MIGRATION; CELL PROLIFERATION; COLONY FORMATION; DNA METHYLATION; GENE EXPRESSION; GENE FUNCTION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; METHYLATION; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WOUND HEALING;

AZACITIDINE; CADHERINS; CARCINOMA, NON-SMALL-CELL LUNG; CASE-CONTROL STUDIES; CELL LINE, TUMOR; CELL PROLIFERATION; DNA METHYLATION; DOWN-REGULATION; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; GENES, TUMOR SUPPRESSOR; HISTONE DEACETYLASE INHIBITORS; HUMANS; HYDROXAMIC ACIDS; LUNG NEOPLASMS; PROMOTER REGIONS, GENETIC; SMOKING;

EID: 84872846920     PISSN: 15740153     EISSN: 18758592     Source Type: Journal    
DOI: 10.3233/CBM-2012-00280     Document Type: Article

References (23)

1. Siegel R, Ward E, Brawley O, and Jemal A. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin. 2011; 61: 212-36. [PudMed: 21685461]
2. Molina J R, Yang P, Cassivi S D, Schild S E, and Adjei A A. Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. Mayo Clin Proc. 2008; 83: 584-94. [PudMed: 18452692] (Pubitemid 351720831)
3. Mulshine J L and Sullivan D C. Clinical practice. Lung cancer screening. N Engl J Med. 2005; 352: 2714-20. [PudMed: 15987920] (Pubitemid 41007826)
4. Wingo P A, Ries L A, Giovino G A, Miller D S, Rosenberg H M, Shopland D R, Thun M J, and Edwards B K. Annual report to the nation on the status of cancer, 1973-1996, with a special section on lung cancer and tobacco smoking. J Natl Cancer Inst. 1999; 91: 675-90. [PudMed: 10218505] (Pubitemid 29234561)
5. Pathak A K, Bhutani M, Kumar S, Mohan A, and Guleria R. Circulating cell-free DNA in plasma/serum of lung cancer patients as a potential screening and prognostic tool. Clin Chem. 2006; 52: 1833-42. [PudMed: 16423903] (Pubitemid 44470688)
6. Feinberg A P and Tycko B. The history of cancer epigenetics. Nat Rev Cancer. 2004; 4: 143-53. [PudMed: 14732866] (Pubitemid 38198742)
7. Brock M V, Hooker C M, Ota-Machida E, Han Y, Guo M, Ames S, Glockner S, Piantadosi S, Gabrielson E, Pridham G, Pelosky K, Belinsky S A, Yang S C, Baylin S B, and Herman J G. DNA methylation markers and early recurrence in stage I lung cancer. N Engl J Med. 2008; 358: 1118-28. [PudMed: 18337602] (Pubitemid 351398486)
8. Ying J, Li H, Seng T J, Langford C, Srivastava G, Tsao SW, Putti T, Murray P, Chan A T, and Tao Q. Functional epigenetics identifies a protocadherin PCDH10 as a candidate tumor suppressor for nasopharyngeal, esophageal and multiple other carcinomas with frequent methylation. Oncogene. 2006; 25: 1070-80. [PudMed: 16247458] (Pubitemid 43277014)
9. Yu J, ChengYY, TaoQ,Cheung KF, LamCN, GengH, Tian L W, Wong Y P, Tong J H, Ying J M, Jin H, To K F, Chan F K, and Sung J J. Methylation of protocadherin 10, a novel tumor suppressor, is associated with poor prognosis in patients with gastric cancer. Gastroenterology. 2009; 136: 640-51 e1. [PudMed: 19084528]
10. Li Z, Li W, Xie J, Wang Y, Tang A, Li X, Ye J, Gui Y, and Cai Z. Epigenetic inactivation of PCDH10 in human prostate cancer cell lines. Cell Biol Int. 2011; 35: 671-6. [PudMed: 21314642]
11. Bertrand K C, Mack S C, Northcott P A, Garzia L, Dubuc A, Pfister S M, Rutka J T,WeissWA, and Taylor M D. PCDH10 is a candidate tumour suppressor gene in medulloblastoma. Childs Nerv Syst. 2011; 27: 1243-9. [PudMed: 21597995]
12. Yu B, Yang H, Zhang C,WuQ, Shao Y, Zhang J, Guan M,Wan J, and ZhangW. High-resolution melting analysis of PCDH10 methylation levels in gastric, colorectal and pancreatic cancers. Neoplasma. 2010; 57: 247-52. [PudMed: 20353276]
13. Kim S Y, Yasuda S, Tanaka H, Yamagata K, and Kim H. Nonclustered protocadherin. Cell Adh Migr. 2011; 5: 97-105. [PudMed: 21173574]
14. Murakami T, Hijikata T,Matsukawa M, Ishikawa H, and Yorifuji H. Zebrafish protocadherin 10 is involved in paraxial mesoderm development and somitogenesis. Dev Dyn. 2006; 235: 506-14. [PudMed: 16261626] (Pubitemid 43100956)
15. Aoki E, Kimura R, Suzuki S T, and Hirano S. Distribution of OL-protocadherin protein in correlation with specific neural compartments and local circuits in the postnatal mouse brain. Neuroscience. 2003; 117: 593-614. [PudMed: 12617965] (Pubitemid 36263154)
16. Hirano S, Yan Q, and Suzuki S T. Expression of a novel protocadherin, OL-protocadherin, in a subset of functional systems of the developing mouse brain. J Neurosci. 1999; 19: 995-1005. [PudMed: 9920663] (Pubitemid 29066162)
17. Wolverton T and Lalande M. Identification and characterization of three members of a novel subclass of protocadherins. Genomics. 2001; 76: 66-72. [PudMed: 11549318] (Pubitemid 32744625)
18. Macones G A, Odibo A, Cahill A, and Stamilio D. Discussion: 'Testing for biomarkers after ASC-US Pap smears' by Lin et al. Am J Obstet Gynecol. 2011; 204: e12-3. [PudMed: 21187191]
19. Lin C J, Lai H C,Wang K H, Hsiung C A, Liu HW, Ding D C, Hsieh C Y, and Chu T Y. Testing for methylated PCDH10 or WT1 is superior to the HPV test in detecting severe neoplasms (CIN3 or greater) in the triage of ASC-US smear results. Am J Obstet Gynecol. 2011; 204: 21 e1-7. [PudMed: 20833385]
20. Villeneuve P J and Mao Y. Lifetime probability of developing lung cancer, by smoking status, Canada. Can J Public Health. 1994; 85: 385-8. [PudMed: 7895211]
21. Lin R K, Hsieh Y S, Lin P, Hsu H S, Chen C Y, Tang Y A, Lee C F, andWang Y C. The tobacco-specific carcinogen NNK induces DNA methyltransferase 1 accumulation and tumor suppressor gene hypermethylation in mice and lung cancer patients. J Clin Invest. 2010; 120: 521-32. [PudMed: 20093774]
22. Rhee I, Jair K W, Yen R W, Lengauer C, Herman J G, Kinzler KW,Vogelstein B, Baylin S B, and Schuebel K E. CpGmethylation is maintained in human cancer cells lacking DNMT1. Nature. 2000; 404: 1003-7. [PudMed: 10801130] (Pubitemid 30243595)
23. Toyooka S, Suzuki M, Tsuda T, Toyooka K O, Maruyama R, Tsukuda K, Fukuyama Y, Iizasa T, Fujisawa T, Shimizu N, Minna JD, and GazdarAF.Dose effect of smoking on aberrant methylation in non-small cell lung cancers. Int J Cancer. 2004; 110: 462-4. [PudMed: 15095316] (Pubitemid 38649902)